<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="94056">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01863355</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0176</org_study_id>
    <nct_id>NCT01863355</nct_id>
  </id_info>
  <brief_title>Comparison of Analgesic Efficacy and Occurrence of Emesis Among Different Background Infusion and Bolus Administration Regimens of Fentanyl Based Intravenous Patient-controlled Analgesia in Patients After Laparoscopic Assisted Gastrectomy - a Randomized Blind Study -</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <authority>South Korea: Korea Food and Drug Administration (KFDA)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fentanyl based intravenous patient controlled analgesia(PCA)is popular method for
      postoperative pain control, but information regarding optimal dose of fentanyl in IV PCA is
      currently lacking. We thus determine appropriate dose of fentanyl (bolus dose and background
      infusion rate) for effective pain control with minimal side effects such as nausea and
      vomiting
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain score(VAS) within 48hrs after surgery</measure>
    <time_frame>Pain socre after surgery 1) within 30min-6hrs, 2) within 6-24hrs, 3) within 24hrs-48hrs</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain score after surgery within 48hrs after laparoscopic gastrectomy</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">225</enrollment>
  <condition>The Patients With Gastric Cancer Who Are Scheduled to Receive Laparoscopy Assisted Gastrectomy</condition>
  <arm_group>
    <arm_group_label>B0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(basal rate 0cc/hr, bolus 3cc, lockout time 10min)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>(basal rate 1cc/hr, bolus 2cc, lockout time 10min)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>(basal rate 2cc/hr, bolus 1cc, lockout time 10min)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>B0 group: bolus 0.6mcg/kg without background infusion</intervention_name>
    <arm_group_label>B0</arm_group_label>
    <other_name>Fentanyl based intraveonus patient controlled analgesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BL group: bolus 0.4mcg/kg with background infusion rate 0.2mcg/kg/hr</intervention_name>
    <arm_group_label>BL</arm_group_label>
    <other_name>Fentanyl based intraveonus patient controlled analgesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BH group: bolus 0.2mcg/kg with background infusion rate 0.4mcg/kg/hr</intervention_name>
    <arm_group_label>BH</arm_group_label>
    <other_name>Fentanyl based intraveonus patient controlled analgesia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 20 and 70

          -  ASA class I and II

          -  Gastric cancer patients who are scheduled to receive laparoscopic gastrectomy

        Exclusion Criteria:

          -  Cardiovascular disease(uncontrolled hypertension, unstable angina, congestive heart
             failure, etc.)

          -  Renal failure

          -  Liver failure

          -  Chronic drug or alcohol abuser

          -  Anti-cancer chemotherapy

          -  Chronic opioid use

          -  Use of antiemetics within 24hrs for nausea and vomiting
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kwan-woong Choi</last_name>
    <phone>(82) 2-2227-4613</phone>
    <email>sanctum@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Severance Hospital, Yonsei University Health System</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kwan-woong Choi</last_name>
      <phone>(82) 2-2227-4613</phone>
      <email>sanctum@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 22, 2013</lastchanged_date>
  <firstreceived_date>May 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IntravenousPCA, fentanyl, postoperative pain, laparoscopic gastrectomy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
